Pyridoxal
CAS 66-72-8
Pyridoxal (CAS 66-72-8) is a Phase 3 pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 34886.75833333333 nM | 12 | - |
| - | AC50 | 7996 nM | 2 | - |
| - | IC50 | 19976.309999999998 nM | 1 | - |
| - | Ki | 30000 nM | 1 | - |
| Aldehyde oxidase Enzyme |
Ki | 4.52 | - | Homo sapiens |
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Hepatic function abnormal | 39 | 104.318 | 10019670 |
| Interstitial lung disease | 41 | 93.301 | 10022611 |
| Palmar-plantar erythrodysaesthesia syndrome | 21 | 56.848 | 10033553 |
| Platelet count decreased | 30 | 42.739 | 10035528 |
| Osteonecrosis of jaw | 18 | 42.387 | 10064658 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Pyridoxal used for in pharmaceutical contexts?
Pyridoxal (CAS 66-72-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Pyridoxal?
Pyridoxal has 0 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Hepatic function abnormal, Interstitial lung disease, Palmar-plantar erythrodysaesthesia syndrome, Platelet count decreased, Osteonecrosis of jaw. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Pyridoxal also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Pyridoxal with EU status "permitted".
What clinical phase is Pyridoxal in?
Pyridoxal is rendered with ChEMBL max phase 3.
What bioactivity targets are documented for Pyridoxal?
Pyridoxal has 4 bioactivity rows in this page query. Rendered target entries include Aldehyde oxidase.